Alcon Inc. — Company profile
Healthcare · Medical Instruments & Supplies · Switzerland
Last price 71.45 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 34.68B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Details
| Name | Alcon Inc. |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Employees | 25000 |
| Founded | 1945 |
| Ceo | David Endicott |
| Country | Switzerland |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | CH0432492467 |
| Cusip | H01301128 |
| Cik | 0001167379 |
| Sic | 3851 |
Key executives
| Name | Title |
|---|---|
| David J. Endicott | Chief Executive Officer and Director |
| Timothy C. Stonesifer | Senior Vice President and Chief Financial Officer |
| Ian Bell | Senior Vice President and Chief Operating Officer |
| Margaret Buckley | Chief Accounting Officer |
| Dr. Franck Leveiller Ph.D. | SVice President of Global Research and Development and Chief Scientific Officer |
| Muru Murugappan | Senior Vice President and Chief Information and Transformation Officer |
| Royce R. Bedward J.D. | Senior Vice President, General Counsel and Corporate Secretary |
| Kimberly Martin | Senior Vice President and Chief Human Resources and Corporate Communications |
| Leon Sergio Duplan Fraustro | Senior Vice President and President of Americas |
| Laurent Attias | Senior Vice President of Corporate Strategy, Business Development and Licensing (BD&L), M&A |
Contact
| Address | Chemin de Blandonnet 8, Vernier, Geneva, 1214, Switzerland |
| Phone | 41 589 112 110 |
| Website | https://www.alcon.com |